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Endothelium-dependent contraction of canine 
coronary artery is enhanced by crystalloid 
cardioplegic solution 
Experiments were designed to determine whether hyperkalemic crystalloid cardioplegic solution 
enhances endotheliumldependent contraction of coronary arteries. Segments of canine coronary 
arteries (n = 8 in each group) were preserved in cold (4 ° C) crystalloid cardioplegic solution (group 
1) and physiologic solution (group 2) for 60 minutes. Segments of preserved and control (group 3) 
coronary arteries with or without endothelium were suspended in organ chambers to measure 
isometric force. Perfusate hypoxia (oxygen tension 35 --- 5 mm Hg) caused endothelium-dependent 
contraction in the arteries of all three groups. However, vascular segments with endothelium of 
group 1 exhibited hypoxic contraction (68.5% -+ 15.3% of the initial tension contracted by 
prostaglandin F2, ~ 2 × 10 -4 mol/L, p < 0.05) that was significantly greater than contraction of the 
group 2 and group 3 segments with endothelium (26.6% __. 5.6% and 20.6 l+ 4.4%). The hypoxic 
contraction in arteries of group 1 could be attenuated by NG-monomethyl-L-arginine, the blocker of 
endothelial cell synthesis of the nitric oxide from L-arginine. The action of NG-monomethyl-L  
arginine could be reversed by L-arginine but not D-arginine. Thus after preservation with cardiople- 
gic solution, augmented endothelium-dependent contraction, occurs by L-arginine-dependent path- 
way, would favor coronary vasospasm after cardiac operation. (J TIiORAC CARDIOVASC SURG 1995; 
109:99-105) 
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Over  the past decade, refinement of techniques 
for myocardial protection and extracorporeal circu- 
lation have lowered the risk of cardiac surgery. The 
effect of global ischemia and reperfusion on coro- 
nary vascular eactivity and endothelial cell function 
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has been investigated recently. 1'2 However, little is 
known about the effects of cardioplegic solution on 
the coronary endothelium. 
Several recent laboratory experiments have sug- 
gested that hyperkalemic cardioplegic solutions im- 
pair endothelial cell production of endothelium- 
derived relaxing factor)' 4 However, in these studies 
the effect of infusion (i.e., shear stress and baro- 
trauma) could not be separated from the effect of 
cardioplegic solution itself. Indeed, it has been 
reported recently that crystalloid cardioplegic solu- 
tion does not alter endothelium-dependent relax- 
ation of the epicardial coronary arteries: However, 
little is known about the effects of hyperkalemic 
cardioplegic solutions, frequently used for myocar- 
dial protection during cardiac surgery, on the endo- 
thelium-dependent contraction of the coronary en- 
dothelium. In this study, using a protocol designed 
to eliminate the variables of infusion pressure and 
shear stress, we evaluated the effect of cardioplegic 
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Fig. 1. Isometric tension recordings of the effect of cardioplegic solution on endothelium-dependent 
responses to hypoxia. Canine coronary arterial segments were preserved with crystalloid cardioplegic 
solution (group 1) and physiologic solution (group 2) at 4 ° C for 60 minutes. The preserved (group 1 to 2) 
and control (group 3) coronary segments were then suspended in an organ chamber gassed with 95% 
oxygen and 5% carbon dioxide (Po2 405 +_ 15 mm Hg) and contracted with prostaglandin F2~ (2 × 10 .6 
tool/L). When the contractile response to prostaglandin F2~ was stable, hypoxia was induced by changing 
to a 95% nitrogen/5% carbon dioxide (Po2 35 -+ 5 mm Hg) gas mix. After 20 minutes, oxygenation was 
reintroduced. 
solutions on endothel ium-dependent contraction of 
coronary endothelial cell function in vitro. 
Methods and material 
Methods 
Animalpreparation. Twenty-four healthy mongrel dogs 
(15 to 20 kg) of either sex were anesthetized with sodium 
pcntobarbital (30 mg/kg intravenous injection), intubated 
with a cuffed cndotracheal tube, and their lungs ventilated 
with a respirator. A left lateral thoracotomy was per- 
formed, and the pericardium was opened and sutured to 
the chest wall to create a pericardial cradle. The heart was 
removed and quickly placed in cold, oxygenated solution 
of the following millimolar concentration: NaC1, 118.3; 
KC1 4.7; MgSO 4 1.2; KH2PO4, 1.2; CaC12, 2.5; NaHCO3, 
25.0; and glucose, 11.1 (physiologic solution). 6"8 All ani- 
mals received human care in compliance with the "Guide 
for the Care and Use of Laboratory Animals" published 
by the National Institutes of Health (NIH publication No. 
85-23, revised 1985). 
In vitro experiments 
ISOLATION OF BLOOD VESSELS. The coronary arteries 
were prepared as segments (4 mm in length) from the left 
circumflex coronary artery or left anterior descending 
artery. During dissection, care was taken to remove as 
much of the surrounding tissues as possible and to avoid 
stretching and rubbing the intimal surface against foreign 
material or the opposite wall of the vessel. To remove the 
endothelium, the vascular segments were placed in saline- 
wetted paper towels. The tips of a pair of watchmaker's 
forceps were inserted into the lumen and the ndothelial 
layer was removed by gently rolling the preparations back 
and forth over the paper for 15 seconds. 6' 7 Earlier studies 
have shown that this procedure successfully removes the 
endothelial cells in canine arteries and veins, while pre- 
serving the ability of the vascular smooth muscle to 
contract. 6-m 
PRESERVATION OF BLOOD VESSELS. The coronary arterial 
segments (from eight dogs in each group) with or without 
endothelium were randomly preserved in the following 
cold solutions (4 ° C) for 60 minutes: group 1--crystalloid 
cardioplegic solution (Plegisol, Abbott Laboratories, 
North Chicago, Ill.) with the following electrolyte compo- 
sition (in milliequivalents per liter): Ca, 2.4; Mg, 32; K, 16; 
Na, 120; and C1, 160; group 2--physiol0gic solution with 
the following millimolar concentration: NaC1, 118.3; KC1 
4.7; MgSO4, 1.2; KH2PO 4, 1.2; CaC12, 2.5; NaHCO3, 25.0; 
and glucose, 11.1. 6-8 In group 3 (control group), however, 
vascular segments were placed into the organ chambers 
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filled with physiologic solution (37 ° C) immediately after 
harvest without preservation. 
ORGAN CHAMBER EXeER[MErCrs. Segments of preserved 
and control coronary arteries (group 1 to group 3) with or 
without endothelium were suspended in organ chambers 
(25 ml) containing physiologic solution (37 ° C, aerated 
with 95% oxygen and 5% carbon dioxide, oxygen tension 
[PO2] 405 + 15 mm Hg, pH 7.4). Isometric tension Was 
recorded with strain-gauge force transducers. The blood 
vessels prepared as segments were suspended between 
two stainless teel wire stirrups passing through the lu- 
men. The tissues were placed at the optimal point of their 
length-tension relationship, as determined by the re- 
sponse to a standard concentration of potassium ions (20 
mmol/L).6, 7 After this procedure, the preparations were 
allowed to equilibrate of their optimal length for 45 
minutes before the experiments. 
DRUGS. The drugs, acetylcholine chloride, potassium 
chloride, adenosine diphosphate, D-arginine, L-arginine, 
(_)  isoproterenol, prostaglandin F2~ , and sodium nitro- 
prusside, were obtained from Sigma Chemical Co., St. 
Louis, Missouri. NG-monoethyl-L-arginine (L-NMMA) 
was acquired from Calbiochem Corp., San Diego, Califor- 
nia. All drugs were prepared with distilled water. The 
concentrations are expressed as final molar concentration 
in the organ chambers. 
Commercial crystalloid cardioplegic solution was pre- 
pared before each experiment by the addition of 24 mEq of 
sodium bicarbonate o 1000 ml of Plegisol solution (Abbott 
Laboratories). Solutions were kept at 4 ° C until used. 
CALCULATIONS AND STATISTICAL ANALYSIS. The data 
were expressed as means -+ standard error of the mean. In 
all experiments, n refers to the number of animals from 
which blood vessels were taken. Although not always 
mentioned in the protocol, the role of the endothelium in
the observed phenomena was determined systematically 
by comparing blood vessels (segments) with or without 
endothelium to avoid repetition. Wherever possible, ex- 
periments were conducted in parallel on tissues from the 
same animal, to account for time-dependent changes in 
responsiveness of tissues. The responses gained from 
segments contracted with prostaglandin F2~ were ex- 
pressed as percent changes from the contracted levels. 
With regard to relaxations, the negative logarithm of the 
effective concentration (moles per liter) of agonist hat 
caused 50% inhibition of the contraction (i.e., the median 
effective dose, ECso ) to prostaglandin F2~ was calculated 
for concentration-response curves. For contractions, the 
maximal response (in grams of tension) and ECso concen- 
tration of agonist inducing the half-maximal contraction 
were determined. The means of the values were pre- 
sented. Statistical evaluation of data between groups was 
performed by analysis of variance, and Student's t test was 
used when analysis of variance showed significance. Sta- 
tistical significance was set at a probability value of less 
than 0.05. 
Protocol. Segments of coronary artery with or without 
endothelium from the same animal were placed in our 
eight-bath organ chamber system, studied, and compared. 
The following procedures were performed: 
1. Segments were preserved in the cold solution (4 ° C) 
for 60 minutes, except vascular segments of group 3. 
Table I. Endothelium-independent vascular smooth 
muscle contractions of segments of canine coronary 
arteries 
Group 1 Group 2 Group 3
ECso* 
Potassium 
With endothelium 10.3 + 0.5 10.0 _+ 0.6 9.5 -+ 0.4 
Without endothelium 9.7 ± 0.4 9.4 -+ 0.7 9.3 -+ 0.5 
Prostaglandin F2~ 
With endothelium 5.7 + 0.5 5.4 -+ 0.2 5.3 -+ 0.5 
Without endothelium 6.0 ± 0.4 6.3 -+ 0.5 5.9 + 0.5 
Potassium 
With endothelium 
Maximal contraction (grn)t 
10.72 + 0.82 11.05 ± 0.91 10.78 -+ 1.27 
Without endothelium 11.23 + 1.45 10.89 _+ 1.37 11.52 - 0.81 
Prostaglandin F2~ 
With endothelium 10.25 --- 1.45 10.50 + 1.37 10.53 _+ 0.97 
Without endothelium 11.27 --+ 1.33 10.56 -+ 1.22 11.41 _+ 1.51 
Values were given as means -+standard error of the mean. Sample size for
all groups was 8. There was no significant difference b tween groups. 
*Concentration f agonist inducing the half-maximal contraction ex- 
pressed as mmol/L for potassium-induced contractions and as -log mol/L 
for prostaglandin F2=-induced contractions. 
?Values were given as means + standard error of the mean of the maximal 
contraction induced by agonists. 
2. Segments were suspended in organ chambers (25 ml) 
containing physiologic solution (37 ° C). 
3. Studies of endothelium-dependent relaxation were 
done. Segments (with and without endothelium) of coro- 
nary artery from animals were suspended in organ cham- 
bers. They were contracted with prostaglandin F2~ (2 × 
10 -6 tool/L) and then exposed to increasing concentra- 
tions (10 -9 to 10 -4 tool/L) of acetylcholine and adenosine 
diphosphate. 
4. Studies of endothelium-independent r laxation were 
done. To test the ability of the smooth muscle to relax, we 
obtained concentration-response curves to sodium nitro- 
prusside (mediated by cyclic guanosine monophosphate, 
10 -9 to 10 -4 mol/L) and isoproterenol (mediated by cyclic 
adenosine monophosphate, 10-9 to 10 -4 mol/L) after 
they were contracted with prostaglandin F2~ , (2 × 10 -6 
tool/L). 
5. Studies of endothelium-dependent contraction to 
hypoxia were done. The vascular segments with or without 
endothelium were contracted with prostaglandin Fz~ (2 × 
10 -6 tool/L) (initial tension) in an organ chamber gassed 
with 95% oxygen and 5% carbon dioxide (Po~ 405 -+ 15 
mm Hg). When the contractile response to prostaglandin 
F2~ was stable, hypoxia was induced by aerating the organ 
bath with a mixture of 95% nitrogen and 5% carbon 
dioxide (pH 7.4, Po2 35 -+ 5 mm Hg, 20 minutes). 2'6 After 
20 minutes, oxygenation was reintroduced. Vascular seg- 
ments were exposed to only one hypoxic period. 
6. Studies of endothelium-independent co raction were 
done. To test he ability of the smooth muscle to contract, we 
obtained concentration-response curves to potassium ions (5 
to 50 retool/L, voltage-dependent) and prostaglandin Fa~ 
(10 -9 to 10 -4 mol/L, receptor-dependent). 
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Fig. 2. Effect of hypoxia (95% nitrogen/5% carbon dioxide) on t nsion in contracted (by prostaglandin F2~ 
2 × 10 -6 mol/t)  canine coronary arterial segments with endothelium of all threegroups. Data are shown 
as means -+ standard error of the mean and are expressed as percent change from the initial contraction 
to prostaglandin F2~ (zero on y axis). *Significant difference from segments with endothelium of other 
groups. 
Results 
Endothelium-dependent contraction to hypoxia. 
Preserved (group 1 and group 2) and control (group 
3) coronary arterial segments with and without 
endothelium had comparable contractile responses 
to prostaglandin F2~ (initial tension, Fig. 1 and 
Table I). On exposure to hypoxia, contracted pre- 
served and control coronary segments with endothe- 
lium exhibited comparable relaxations (hypoxic re- 
laxation) (groups 1 to 3, 34% _+ 5%, 37% + 4%, and 
39% _+ 4% of initial tension, respectively, p > 0.05; 
Fig. 2). In vascular segments with endothelium of all 
three groups, hypoxia induced contractions (hypoxic 
contraction) that were significantly greater than in 
segments without endothelium (Fig. 1). However, 
coronary arterial segments of group I with endothe- 
lium exhibited augmented contractions to hypoxia 
(68.5% +_ 15.3% greater contraction than initial 
tension), which were significantly greater than those 
in segments of groups 2 and 3 with endothelium 
(26.6% _+ 5.6% and 20.6% + 4.4% greater contrac- 
tion than initial tension, respectively, p < 0.02) 
(Figs. 1 and 2). This endothelium-dependent hy- 
poxic contraction could be attenuated by pretreat- 
ment with L-NMMA (10 -5 tool/L, a nitric oxide 
synthase inhibitor) in segments of all three groups 
with endothelium (Fig. 3). The effect of L-NMMA 
could be blocked with L-arginine (precursor of nitric 
oxide, 10 -4 tool/L) but not by I>arginine (analog of 
L-arginine, 10 -4 tool/L) (Fig. 3). L-NMMA, L-argi- 
nine, and D-arginine had no effects on the hypoxic 
responses of preserved and control segments with- 
out endothelium. L-NMMA also did not change the 
baseline tension (before contraction with prostag- 
landin F2~ ) of the preserved and control segments 
with or without endothelium. 
Endothelium-dependent relaxation. Increasing 
concentrations (10 -9 to 10 -4 tool/L) of acetylcho- 
line and adenosine diphosphate induced compara- 
ble concentration-dependent r laxation in coronary 
artery segments with endothelium in all groups. 
They produced no significant change in tension in 
coronary artery segments without endothelium. In 
all groups, the maximal relaxation or sensitivity 
(ECs0) to agonist-induced relaxation in coronary 
artery segments with endothelium did not change 
(Table II). 
Endothelium-independeut relaxation. Increasing 
concentrations (10 -9 to 10 -4 tool/L) of isoprotere- 
nol and sodium nitroprusside nduced comparable 
concentration-dependent r laxation in coronary ar- 
tery segments without endothelium in all groups. In 
all groups, the maximal relaxation induced by iso- 
proterenol or sodium nitroprusside was not altered 
in coronary artery segments without endothelium, 
nor did this induction change the sensitivity to 
relaxation of the vascular smooth muscle (see Table 
II). 
Endothelinm-independent contraction. Increasing 
concentration of potassium ions (5 to 50 mmol/L) 
and prostaglandin F2~ (10 -9 to 10 -4 tool/L) induced 
comparable, concentration-dependent contraction 
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Fig. 3. Effect of hypoxia nd drugs on tension in contracted (by prostaglandin F2, ~ 2 × 10 -6 mol/L) canine 
coronary arterial segments with endothelium of all three groups. Data are shown as means _+ standard 
error of the mean and expressed as percent of the initial contraction to prostaglandin F2~. *Significant 
difference from control untreated segments (group 3) with endothelium (p < 0.02). #Significant difference 
from untreated segments with endothelium in the same group (p < 0.05). L-NMMA, NC-monomethyl-I. - 
arginine. 
of arterial segments with or without endothelium in 
all groups. The maximal response or the sensitivity 
to these agonists did not have any significant 
changes in any of the groups (see Table I). 
Discussion 
The major finding of this study is that hypoxia 
induced augmented endothelium-dependent con- 
traction in canine coronary endothelium preserved 
with crystalloid cardioplegic solution. L-NMMA (a 
nitric oxide synthase inhibitor) attenuated this en- 
dothelium-dependent hypoxic contraction, indicat- 
ing that this hypoxic contraction was induced,by an 
L-arginine-dependent pathway. We also found that 
hyperkalemic rystalloid cardioplegic solution did 
not alter endothelium-dependent relaxation func- 
tion of epicardial coronary arteries. In addition, 
smooth muscle contraction in response to potassium 
ions (voltage-dependent) or prostaglandin F2~ (re- 
ceptor-dependent) and relaxation in response to 
isoproterenol (cyclic adenosine monophosphate- 
mediated) or sodium nitroprusside (cyclic guanosine 
monophosphate-mediated) was well preserved after 
exposure to crystalloid cardioplegic solution. 
The coronary endothelium releases endothelium- 
derived relaxing factor(s), which relaxes the under- 
lying vascular smooth muscle. Endothelium-derived 
relaxing factor regulates arterial tone and thus par- 
Table II. Endothelium-dependent and-&dependent 
relaxation of segments of canine coronary arteries 
Group 1 Group 2 Group 3
ECso (-log mol/L) * 
With endothelium 
Acetylcholine 6.85 ± 0.31 7.10 ± 0.11 6.92 --- 0. 4 
Adenosine diphosphate 6.65 -+ 0.22 6.52 ± 0.14 6.49 ± 0.08 
Without endothelium 
Isoproterenol 
Sodium nitroprusside 
7.71 ± 0.05 7.63 + 0.10 7.52 --- 0.15 
7.95 -+ 0.08 7.91 + 0.12 7.87 ± 0.09 
Maximal relaxation (%) ? 
With endothelium 
Acetylcholine 95.5 ± 2.1 96.0 _+ 1.1 96.5 + 2.5 
Adenosine diphosphate 94.5 _+ 2.7 92.7 + 4.1 93.5 ± 3.5 
Without endothelium 
Isoproterenol 100 100 100 
Sodium nitroprusside 100 100 100 
Sample size for all groups was 8. There was no significant difference 
between groups. 
*Values were given as means Z standard error ofthe mean of the negative 
logarithms of the concentration (mol/L) f agonists causing 50% inhibition 
of contractions (i.e., the median effective dose) induced by prostaglandin 
F2~ (2 X 10 .6 tool/L). 
tValues were given as means ± standard error of the mean of the maximal 
inhibition of contraction induced by prostaglandin F2~ (2 × 10 -6 mol/L) 
with the agonists (10-4 tool/L). 
ticipates in control of coronary blood flow. In the 
normal coronary artery, release of endothelium- 
derived relaxing factor is stimulated by aggregating 
platelets, shear stress, and other vasoactive agents. 
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The major endothelium-derived relaxing factor is 
nitric oxide, which serves as the coronary arteries' 
own physiologic nitrovasodilator. 11 In addition to 
relaxing vascular smooth muscle, endothelium-de- 
rived relaxing factor also prevents platelet adhe- 
sion 12 and aggregation 13 and promotes platelet 
disaggregation i  normal blood vessels. 14 Thus en- 
dothelium-derived relaxing factor induces vasodila- 
tion directly and inhibits platelet-mediated vaso- 
spasm and thrombus formation. 
We 1 have previously demonstrated that endothe- 
lium-dependent relaxation was impaired after car- 
diac global ischemia nd reperfusion. Impaired re- 
lease of relaxing factor would promote platelet 
adhesion and aggregation as well as platelet-induced 
construction of the underlying smooth muscle. 
These events could lead to vasospasm and throm- 
bosis. 9 Previous reports have suggested that hy- 
perkalemic ardioplegic solutions impair endothe- 
lial cell production of endothelium-derived r laxing 
factor. 3'4 However, Evora, Pearson, and Schaff 5
reported recently that crystalloid cardioplegic solu- 
tion does not alter endothelium-dependent relax- 
ation of the epicardial coronary arteries. Our data 
also clearly showed that crystalloid cardioplegic 
solution does not alter endothelium-dependent r - 
laxation to acetylcholine and adenosine diphosphate 
of epicardial coronary arteries. Crystalloid car- 
dioplegic solution does not alter endothelium-inde- 
pendent smooth muscle relaxation to isoproterenol 
and sodium nitroprusside. 
The coronary endothelium can also produce con- 
tracting factor. When exposed to hypoxia or regener- 
ated after mechanical injury, the endothelium ex- 
hibits augmented contraction, 6-7' xo, ls-18 We 6, 8,17,18 
have described endothelium-dependent contractions 
caused by hypoxia in the human and canine internal 
mammary arteries. We 2 also found that the endother 
lium-dependent contraction was enhanced after coro- 
nary ischemia nd repeffusion. Augmented endothe- 
lium-dependent contraction after coronary ischemia 
and reperfusion 2 appear to be important factors in 
coronary vasospasm after ischemia nd reperfusion f 
coronary arteries. 
Even before the importance of endothelium-de- 
pendent responses was recognized, investigators 
demonstrated that hypoxia augments contraction to 
several vasoactive agents in isolated blood ves- 
sels. 19-21 Vanhoutte and coworkers 1°'22'23 subse- 
quently determined that in canine coronary and 
femoral arteries, hypoxic augmentation of contrac- 
tion was due to a diffusible factor released by the 
endothelium, which they termed endothelium-de- 
rived contracting factor. Endothelium-dependent 
contraction to hypoxia in these canine blood vessels 
is not modified by inhibitors of cyclooxygenase, 
lipoxygenase, phospholipase A2, serotonergic or his- 
taminergic blockers, the radical generators quina- 
crine or phenidone, or by methylene blue. a° In 
addition, these finding of the rapid onset and rever- 
sal of the contraction and the inability to bioassay 
the contracting factor rule out the vasoconstrictor 
peptide endothelin as the mediator of this re- 
sponse. 23 
Endothelium-dependent contraction to hypoxia 
in the canine coronary artery and internal mammary 
artery can be blocked by L-NMMA, a' 6, 8 the com- 
petitive inhibitor of nitric oxide synthesis from L- 
arginine. 24 Nitric oxide has been identified as the 
active component of endothelium-derived relaxing 
factor. 11 In this study, we found that hyperkalemic 
cardioplegic solution could induce augmented endo- 
thelium-dependent contraction in canine coronary 
endothelium on exposure to hypoxia. This endothe- 
lium-dependent hypoxic contraction could be atten- 
uated by L-NMMA, which indicates that this hypoxic 
contraction was induced by an L-arginine-dependent 
pathway. Such a mechanism would be consistent 
with the finding of enhanced endothelium-depen- 
dent contraction to hypoxia in the human internal 
mammary artery 6' s and augmented production of 
endothelium-derived contracting factor following 
canine coronary reperfusion after global ischemia. 2 
Coronary arteries may be exposed to hypoxia in 
the perioperative period after cardiac operations. 
Low cardiac output, intrapulmonary shunting of 
blood, and alveolar hypoventilation are recognized 
causes of perioperative hypoxemia. However, coro- 
nary arteries may also be exposed to local hypoxia or 
ischemia primarily to occluded vein grafts or vaso- 
spastic internal mammary arterial grafts 6' 8 in cases 
of coronary artery bypass grafting or secondarily to 
impaired release of endothelium-derived relaxing 
factor from coronary endothelium after global isch- 
emia and reperfusion. 1 It has been shown that 
endothelium-dependent r laxation was impaired af- 
ter cardiac local or global ischemia and reperfu- 
sion. 1'25'26 Because endothelium-derived relaxing 
factor relaxes vascular smooth muscle and inhibits 
platelet adhesion and aggregation in the blood 
vessel, such an impairment could put the graft at risk 
for ischemic events uch as vasospasm and throm- 
bosis. The present study suggests that if an ischemic 
event were to occur after a cardiac operation, tissue 
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hypoxia would increase production of endothelium- 
derived contracting factor by the coronary endothe- 
lium that was preserved by cardioplegic solution and 
injured by ischemia and reperfusion during cardiac 
surgery, thereby inducing or exacerbating coronary 
vasospasm. Indeed, such a sequence of events could 
lead to cardiovascular collapse at a time when the 
heart is exquisitely sensitive to ischemia because of 
preexisting myocardial disease or intraoperative in- 
jury. 
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